Protalix BioTherapeutics
PLX
#8625
Rank
S$0.17 B
Marketcap
$2.38
Share price
1.15%
Change (1 day)
3.33%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -S$10.61 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are S$45.66 Million. In 2023 the company made an earning of S$15.92 Million, an increase over its 2022 earnings that were of -S$16.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$10.61 Million-166.57%
2023 S$15.92 M-199.05%
2022 -S$16.09 Million-40.38%
2021 -S$26.98 Million-732.31%
2020 S$4.26 M-130.53%
2019 -S$13.98 Million189.85%
2018 -S$4.83 Million-95.29%
2017 -S$0.11 Billion308.12%
2016 -S$25.09 Million-32.37%
2015 -S$37.1 Million10.11%
2014 -S$33.69 Million-7.59%
2013 -S$36.46 Million
2011 -S$42.22 Million-19.39%
2010 -S$52.37 Million20.87%
2009 -S$43.33 Million32.26%
2008 -S$32.76 Million-5.46%
2007 -S$34.65 Million
2004 -S$0.23 Million12.35%
2003 -S$0.2 Million-11.1%
2002 -S$0.23 Million-57.03%
2001 -S$0.53 Million1.03%
2000 -S$0.52 Million-53.22%
1999 -S$1.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$92.63 Million 781.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.88 B-8,564.81%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.40 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.56 B-5,513.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel